F.L. Putnam Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.1M Buy
74,082
+17,797
+32% +$18M 1.01% 21
2025
Q4
$60.5M Buy
56,285
+2,471
+5% +$2.36M 0.88% 22
2025
Q3
$41.1M Buy
53,814
+27,447
+104% +$20.4M 0.61% 30
2025
Q2
$20.6M Sell
26,367
-9,401
-26% -$7.31M 0.35% 58
2025
Q1
$29.5M Buy
35,768
+328
+0.9% +$273K 0.55% 38
2024
Q4
$27.4M Sell
35,440
-3,870
-10% -$3.2M 0.5% 43
2024
Q3
$29.3M Buy
39,310
+5,938
+18% +$5.34M 0.53% 40
2024
Q2
$30.2M Buy
33,372
+3,104
+10% +$2.48M 0.57% 35
2024
Q1
$23.5M Sell
30,268
-563
-2% -$401K 0.5% 44
2023
Q4
$18M Sell
30,831
-352
-1% -$205K 0.42% 55
2023
Q3
$16.7M Sell
31,183
-3,690
-11% -$1.9M 0.46% 49
2023
Q2
$16.4M Buy
34,873
+2,570
+8% +$1.08M 0.45% 51
2023
Q1
$11.1M Sell
32,303
-2,409
-7% -$812K 0.36% 65
2022
Q4
$12.7M Sell
34,712
-709
-2% -$251K 0.46% 56
2022
Q3
$11.5M Buy
35,421
+627
+2% +$199K 0.45% 51
2022
Q2
$11.3M Buy
34,794
+2,161
+7% +$649K 0.41% 57
2022
Q1
$9.35M Buy
32,633
+2,547
+8% +$655K 0.3% 72
2021
Q4
$8.31M Buy
30,086
+11,461
+62% +$2.91M 0.25% 79
2021
Q3
$4.3M Buy
18,625
+111
+0.6% +$27.4K 0.15% 117
2021
Q2
$4.25M Buy
18,514
+7,948
+75% +$1.6M 0.15% 120
2021
Q1
$1.97M Sell
10,566
-220
-2% -$43K 0.09% 144
2020
Q4
$1.82M Sell
10,786
-18,246
-63% -$2.72M 0.09% 136
2020
Q3
$4.3M Sell
29,032
-678
-2% -$105K 0.24% 84
2020
Q2
$4.88M Buy
29,710
+2,964
+11% +$455K 0.29% 79
2020
Q1
$3.71M Buy
26,746
+1,893
+8% +$260K 0.28% 84
2019
Q4
$3.27M Sell
24,853
-8,657
-26% -$1M 0.2% 104
2019
Q3
$3.75M Buy
33,510
+2,439
+8% +$272K 0.26% 92
2019
Q2
$3.44M Buy
31,071
+7,656
+33% +$902K 0.28% 90
2019
Q1
$3.04M Buy
23,415
+8,346
+55% +$1.01M 0.26% 94
2018
Q4
$1.74M Buy
15,069
+12,734
+545% +$1.42M 0.19% 101
2018
Q3
$251K Buy
+2,335
New +$233K 0.02% 200
2018
Q2
Sell
-5,105
Closed -$395K 228
2018
Q1
$395K Sell
5,105
-26,941
-84% -$2.17M 0.04% 193
2017
Q4
$2.71M Buy
32,046
+5,877
+22% +$500K 0.25% 96
2017
Q3
$2.24M Buy
+26,169
New +$2.15M 0.21% 99
2017
Q1
$1.77M Buy
21,076
+5,778
+38% +$463K 0.18% 109
2016
Q4
$1.13M Sell
15,298
-6,990
-31% -$521K 0.13% 112
2016
Q3
$1.79M Buy
+22,288
New +$1.78M 0.2% 87
2016
Q1
Sell
-2,505
Closed -$211K 173
2015
Q4
$211K Buy
+2,505
New +$208K 0.02% 163
2013
Q4
Sell
-46,219
Closed -$2.33M 202
2013
Q3
$2.33M Sell
46,219
-266
-0.6% -$13.9K 0.31% 95
2013
Q2
$2.28M Buy
+46,485
New +$2.53M 0.33% 95

Other funds holding LLY

F.L. Putnam Investment Management's LLY Position: Q1 2026 in Review

F.L. Putnam Investment Management increased its Eli Lilly (LLY) stake by 32% in Q1 2026, buying an estimated $18M and bringing the position to 74,082 shares worth $68.1M. The position accounts for 1.01% of the portfolio, ranked #21.

F.L. Putnam Investment Management first reported a position in LLY in Q2 2013 and has held it in 40 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • F.L. Putnam Investment Management held 74,082 shares of Eli Lilly worth $68.1M as of Q1 2026.
  • F.L. Putnam Investment Management bought 17,797 Eli Lilly shares in Q1 2026, an estimated $18M.
  • Eli Lilly made up 1.01% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #21 holding.
  • F.L. Putnam Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 40 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.